Cargando…
Early acute kidney injury and transition to renal replacement therapy in critically ill patients with SARS-CoV-2 requiring veno-venous extracorporeal membrane oxygenation
BACKGROUND: Critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requiring veno-venous extracorporeal membrane oxygenation (vv-ECMO) are at risk for acute kidney injury (AKI). Currently, the incidence of AKI and progression to kidney replacement therapy (RRT) in...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673790/ https://www.ncbi.nlm.nih.gov/pubmed/37999776 http://dx.doi.org/10.1186/s13613-023-01205-x |
_version_ | 1785149635362291712 |
---|---|
author | Roedl, Kevin De Rosa, Silvia Fischer, Marlene Braunsteiner, Josephine Schmidt-Lauber, Christian Jarczak, Dominik Huber, Tobias B. Kluge, Stefan Wichmann, Dominic |
author_facet | Roedl, Kevin De Rosa, Silvia Fischer, Marlene Braunsteiner, Josephine Schmidt-Lauber, Christian Jarczak, Dominik Huber, Tobias B. Kluge, Stefan Wichmann, Dominic |
author_sort | Roedl, Kevin |
collection | PubMed |
description | BACKGROUND: Critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requiring veno-venous extracorporeal membrane oxygenation (vv-ECMO) are at risk for acute kidney injury (AKI). Currently, the incidence of AKI and progression to kidney replacement therapy (RRT) in critically ill patients with vv-ECMO for severe COVID-19 and implications on outcome are still unclear. METHODS: Retrospective analysis at the University Medical Center Hamburg-Eppendorf (Germany) between March 1st, 2020 and July 31st, 2021. Demographics, clinical parameters, AKI, type of organ support, length of ICU stay, mortality and severity scores were assessed. RESULTS: Ninety-one critically ill patients with SARS-CoV-2 requiring ECMO were included. The median age of the study population was 57 (IQR 49–64) years and 67% (n = 61) were male. The median SAPS II and SOFA Score on admission were 40 (34–46) and 12 (10–14) points, respectively. We observed that 45% (n = 41) developed early-AKI, 38% (n = 35) late-AKI and 16% (n = 15) no AKI during the ICU stay. Overall, 70% (n = 64) of patients required RRT during the ICU stay, 93% with early-AKI and 74% with late-AKI. Risk factors for early-AKI were younger age (OR 0.94, 95% CI 0.90–0.99, p = 0.02) and SAPS II (OR 1.12, 95% CI 1.06–1.19, p < 0.001). Patients with and without RRT were comparable regarding baseline characteristics. SAPS II (41 vs. 37 points, p < 0.05) and SOFA score (13 vs. 12 points, p < 0.05) on admission were significantly higher in patients receiving RRT. The median duration of ICU (36 vs. 28 days, p = 0.27) stay was longer in patients with RRT. An ICU mortality rate in patients with RRT in 69% (n = 44) and in patients without RRT of 56% (n = 27) was observed (p = 0.23). CONCLUSION: Critically ill patients with severe SARS-CoV-2 related ARDS requiring vv-ECMO are at high risk of early acute kidney injury. Early-AKI is associated with age and severity of illness, and presents with high need for RRT. Mortality in patients with RRT was comparable to patients without RRT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13613-023-01205-x. |
format | Online Article Text |
id | pubmed-10673790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-106737902023-11-24 Early acute kidney injury and transition to renal replacement therapy in critically ill patients with SARS-CoV-2 requiring veno-venous extracorporeal membrane oxygenation Roedl, Kevin De Rosa, Silvia Fischer, Marlene Braunsteiner, Josephine Schmidt-Lauber, Christian Jarczak, Dominik Huber, Tobias B. Kluge, Stefan Wichmann, Dominic Ann Intensive Care Research BACKGROUND: Critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requiring veno-venous extracorporeal membrane oxygenation (vv-ECMO) are at risk for acute kidney injury (AKI). Currently, the incidence of AKI and progression to kidney replacement therapy (RRT) in critically ill patients with vv-ECMO for severe COVID-19 and implications on outcome are still unclear. METHODS: Retrospective analysis at the University Medical Center Hamburg-Eppendorf (Germany) between March 1st, 2020 and July 31st, 2021. Demographics, clinical parameters, AKI, type of organ support, length of ICU stay, mortality and severity scores were assessed. RESULTS: Ninety-one critically ill patients with SARS-CoV-2 requiring ECMO were included. The median age of the study population was 57 (IQR 49–64) years and 67% (n = 61) were male. The median SAPS II and SOFA Score on admission were 40 (34–46) and 12 (10–14) points, respectively. We observed that 45% (n = 41) developed early-AKI, 38% (n = 35) late-AKI and 16% (n = 15) no AKI during the ICU stay. Overall, 70% (n = 64) of patients required RRT during the ICU stay, 93% with early-AKI and 74% with late-AKI. Risk factors for early-AKI were younger age (OR 0.94, 95% CI 0.90–0.99, p = 0.02) and SAPS II (OR 1.12, 95% CI 1.06–1.19, p < 0.001). Patients with and without RRT were comparable regarding baseline characteristics. SAPS II (41 vs. 37 points, p < 0.05) and SOFA score (13 vs. 12 points, p < 0.05) on admission were significantly higher in patients receiving RRT. The median duration of ICU (36 vs. 28 days, p = 0.27) stay was longer in patients with RRT. An ICU mortality rate in patients with RRT in 69% (n = 44) and in patients without RRT of 56% (n = 27) was observed (p = 0.23). CONCLUSION: Critically ill patients with severe SARS-CoV-2 related ARDS requiring vv-ECMO are at high risk of early acute kidney injury. Early-AKI is associated with age and severity of illness, and presents with high need for RRT. Mortality in patients with RRT was comparable to patients without RRT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13613-023-01205-x. Springer International Publishing 2023-11-24 /pmc/articles/PMC10673790/ /pubmed/37999776 http://dx.doi.org/10.1186/s13613-023-01205-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Roedl, Kevin De Rosa, Silvia Fischer, Marlene Braunsteiner, Josephine Schmidt-Lauber, Christian Jarczak, Dominik Huber, Tobias B. Kluge, Stefan Wichmann, Dominic Early acute kidney injury and transition to renal replacement therapy in critically ill patients with SARS-CoV-2 requiring veno-venous extracorporeal membrane oxygenation |
title | Early acute kidney injury and transition to renal replacement therapy in critically ill patients with SARS-CoV-2 requiring veno-venous extracorporeal membrane oxygenation |
title_full | Early acute kidney injury and transition to renal replacement therapy in critically ill patients with SARS-CoV-2 requiring veno-venous extracorporeal membrane oxygenation |
title_fullStr | Early acute kidney injury and transition to renal replacement therapy in critically ill patients with SARS-CoV-2 requiring veno-venous extracorporeal membrane oxygenation |
title_full_unstemmed | Early acute kidney injury and transition to renal replacement therapy in critically ill patients with SARS-CoV-2 requiring veno-venous extracorporeal membrane oxygenation |
title_short | Early acute kidney injury and transition to renal replacement therapy in critically ill patients with SARS-CoV-2 requiring veno-venous extracorporeal membrane oxygenation |
title_sort | early acute kidney injury and transition to renal replacement therapy in critically ill patients with sars-cov-2 requiring veno-venous extracorporeal membrane oxygenation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673790/ https://www.ncbi.nlm.nih.gov/pubmed/37999776 http://dx.doi.org/10.1186/s13613-023-01205-x |
work_keys_str_mv | AT roedlkevin earlyacutekidneyinjuryandtransitiontorenalreplacementtherapyincriticallyillpatientswithsarscov2requiringvenovenousextracorporealmembraneoxygenation AT derosasilvia earlyacutekidneyinjuryandtransitiontorenalreplacementtherapyincriticallyillpatientswithsarscov2requiringvenovenousextracorporealmembraneoxygenation AT fischermarlene earlyacutekidneyinjuryandtransitiontorenalreplacementtherapyincriticallyillpatientswithsarscov2requiringvenovenousextracorporealmembraneoxygenation AT braunsteinerjosephine earlyacutekidneyinjuryandtransitiontorenalreplacementtherapyincriticallyillpatientswithsarscov2requiringvenovenousextracorporealmembraneoxygenation AT schmidtlauberchristian earlyacutekidneyinjuryandtransitiontorenalreplacementtherapyincriticallyillpatientswithsarscov2requiringvenovenousextracorporealmembraneoxygenation AT jarczakdominik earlyacutekidneyinjuryandtransitiontorenalreplacementtherapyincriticallyillpatientswithsarscov2requiringvenovenousextracorporealmembraneoxygenation AT hubertobiasb earlyacutekidneyinjuryandtransitiontorenalreplacementtherapyincriticallyillpatientswithsarscov2requiringvenovenousextracorporealmembraneoxygenation AT klugestefan earlyacutekidneyinjuryandtransitiontorenalreplacementtherapyincriticallyillpatientswithsarscov2requiringvenovenousextracorporealmembraneoxygenation AT wichmanndominic earlyacutekidneyinjuryandtransitiontorenalreplacementtherapyincriticallyillpatientswithsarscov2requiringvenovenousextracorporealmembraneoxygenation |